|
UBE2D1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.319800E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.373370E-01 |
| Normal-vs-Stage2 |
1.081960E-03 |
| Normal-vs-Stage3 |
7.331900E-02 |
| Normal-vs-Stage4 |
4.980500E-03 |
| Stage1-vs-Stage2 |
1.387590E-02 |
| Stage1-vs-Stage3 |
5.109200E-01 |
| Stage1-vs-Stage4 |
5.369900E-02 |
| Stage2-vs-Stage3 |
7.771900E-02 |
| Stage2-vs-Stage4 |
6.350800E-01 |
| Stage3-vs-Stage4 |
2.043800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.064620E-01 |
| Normal-vs-AfricanAmerican |
3.644200E-02 |
| Normal-vs-Asian |
7.014400E-02 |
| Caucasian-vs-AfricanAmerican |
2.366800E-01 |
| Caucasian-vs-Asian |
6.271800E-01 |
| AfricanAmerican-vs-Asian |
5.705200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.327600E-02 |
| Normal-vs-Female |
5.099700E-02 |
| Male-vs-Female |
3.631000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.301200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.001000E-03 |
| Normal-vs-Age(61-80Yrs) |
4.478400E-03 |
| Normal-vs-Age(81-100Yrs) |
5.825800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.537890E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.282420E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.399800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.444800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.723600E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.484300E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.115400E-01 |
| Classical-VS-Follicular |
5.3651000309074E-09 |
| Classical-VS-Other |
5.435200E-01 |
| Classical-VS-Normal |
3.147800E-01 |
| Tall-VS-Follicular |
2.48869999999179E-05 |
| Tall-VS-Other |
4.047600E-01 |
| Tall-VS-Normal |
9.829800E-01 |
| Follicular-VS-Other |
1.799170E-01 |
| Follicular-VS-Normal |
2.16200000013878E-07 |
| Other-VS-Normal |
3.310400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.460100E-03 |
| Normal-vs-N1 |
1.203190E-01 |
| N0-vs-N1 |
1.969840E-01 |
|
|
